The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting on cancer-specific survival in metastatic castrate-resistant prostate cancer.
 
Kelly Lehner
No Relationships to Disclose
 
Mohamed E. Ahmed
No Relationships to Disclose
 
Raevti Bole
No Relationships to Disclose
 
Jack R. Andrews
No Relationships to Disclose
 
Rimki Haloi
No Relationships to Disclose
 
Michael S. Bold
No Relationships to Disclose
 
Ayse T. Kendi
Research Funding - Endocyte (Inst)
 
R. Jeffrey Karnes
No Relationships to Disclose
 
Eugene D. Kwon
No Relationships to Disclose
 
Alan Haruo Bryce
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Castle Biosciences; Horizon CME; Myovant Sciences; Myovant Sciences; Pfizer; Research to Practice; Research to Practice; Verity Pharmaceuticals
Travel, Accommodations, Expenses - Clovis Oncology (Inst); Phosplatin Therapeutics (Inst)